Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.122
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
9f:16m
|
Linear Mixed Model framework, LME, including Weight
|
0.00566
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:19m
|
Linear Mixed Model framework, LME, including Weight
|
0.683
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:19m
|
Linear Mixed Model framework, LME, including Weight
|
0.711
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Lipase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.972
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Simplified IPGTT / Blood glucose concentration
|
HOM
|
50f:95m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
9f:16m
|
Linear Mixed Model framework, LME, including Weight
|
0.0795
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
9f:19m
|
Linear Mixed Model framework, LME, including Weight
|
0.733
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
9f:19m
|
Linear Mixed Model framework, LME, including Weight
|
0.581
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Creatinine
|
HOM
|
5f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.000319
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Fructosamine
|
HOM
|
5f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0829
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0147
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00847
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0143
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.249
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
7f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.324
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000652
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.416
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.164
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00174
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00760
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.383
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.624
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / UIBC (unsaturated iron binding capacity)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0642
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000186
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.154
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.484
|
Successful |
Ucp1m1H
|
MRC Harwell
|
DEXA / Fat/Body weight
|
HOM
|
10f:19m
|
Linear Mixed Model framework, LME, not including Weight
|
0.248
|
Successful |
Ucp1m1H
|
MRC Harwell
|
DEXA / Fat mass
|
HOM
|
10f:19m
|
Linear Mixed Model framework, LME, not including Weight
|
0.445
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
588f:588m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Calorimetry / Carbon dioxide production
|
HOM
|
574f:983m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.622
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Calorimetry / Oxygen consumption
|
HOM
|
574f:983m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.539
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.463
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.176
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Dysmorphology / fat distribution
|
HOM
|
10f:19m
|
|
|
NotProcessed |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.766
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0476
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
588f:588m
|
|
|
NotProcessed |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Potassium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.144
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.417
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
7f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0756
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0188
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00350
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
7f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.868
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00569
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000284
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Insulin Blood Level / Insulin
|
HOM
|
4f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.116
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00476
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.557
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0474
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.973
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.496
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0140
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0213
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
588f:588m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
f:2m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Ucp1m1H
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.846
|
Successful |
Ucp1m1H
|
MRC Harwell
|
Simplified IPGTT / Glucose response AUC
|
HOM
|
10f:19m
|
Linear Mixed Model framework, LME, including Weight
|
0.684
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
6.13×10-05
|
Successful |
Ucp1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00662
|
Successful |